FK 506 in the treatment of steroid- and OKT3-resistant rejection in renal transplant recipients: reduced dosage and anti-infective prophylaxis.
Kliem
V
V
Abteilung Nephrologie, Medizinische Hochschule Hannover, Germany.
Eberhard
O K
OK
Oldhafer
K
K
Schlitt
H J
HJ
Behrend
M
M
Schaumann
D
D
Pichlmayr
R
R
Koch
K M
KM
Brunkhorst
R
R
D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D000075202:Contraindications; D003404:Creatinine / Q000097:blood; D004305:Dose-Response Relationship, Drug; D004351:Drug Resistance; D005260:Female; D005500:Follow-Up Studies; D015774:Ganciclovir / Q000627:therapeutic use; D006084:Graft Rejection / Q000188:drug therapy* / Q000276:immunology; D006085:Graft Survival; D006509:Hepatitis B / Q000150:complications; D006526:Hepatitis C / Q000150:complications; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D016853:Muromonab-CD3 / Q000627:therapeutic use; D013256:Steroids / Q000627:therapeutic use; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
D000890:Anti-Infective Agents; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D013256:Steroids; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D003404:Creatinine; D001379:Azathioprine; D015774:Ganciclovir; D016559:Tacrolimus